Researchers from the Drug Safety Research Unit are calling for the robust monitoring of the safety of lecanemab, a promising new drug to treat Alzheimer’s Disease (AD). In a review article, published ...

The German pharmaceutical company has tied up with professional services firm Genpact for the work, signing a multi-year agreement for its Pharmacovigilance Artificial Intelligence (PVAI ...

Significant investments in pharmacovigilance research and infrastructure. South America: A developing market with rising healthcare awareness, increasing access to medications, and growing ...